Dose-Related Antihypertensive Properties and the Corresponding Mechanisms of a Chicken Foot Hydrolysate in Hypertensive Rats

Impacto

Downloads

Downloads per month over past year

Mas-Capdevila, Anna and Pons, Zara and Aleixandre De Artiñano, María Amaya and Bravo, Francisca and Muguerza, Begoña (2018) Dose-Related Antihypertensive Properties and the Corresponding Mechanisms of a Chicken Foot Hydrolysate in Hypertensive Rats. Nutrients, 10 (9). p. 1295. ISSN 2072-6643

[thumbnail of nutrients-10-01295.pdf]
Preview
PDF
Creative Commons Attribution.

1MB

Official URL: https://doi.org/10.3390/nu10091295




Abstract

The antihypertensive properties of different doses of a chicken foot hydrolysate, Hpp11 and the mechanisms involved in this effect were investigated. Spontaneously hypertensive rats (SHR) were administered water, Captopril (50 mg/kg) or Hpp11 at different doses (25, 55 and 85 mg/kg), and the systolic blood pressure (SBP) was recorded. The SBP of normotensive Wistar-Kyoto (WKY) rats administered water or Hpp11 was also recorded. Additionally, plasmatic angiotensin-converting enzyme (ACE) activity was determined in the SHR administered Hpp11. Moreover, the relaxation caused by Hpp11 in isolated aortic rings from Sprague-Dawley rats was evaluated. Hpp11 exhibited antihypertensive activity at doses of 55 and 85 mg/kg, with maximum activity 6 h post-administration. At this time, no differences were found between these doses and Captopril. Initial SBP values of 55 and 85 mg/kg were recovered 24 or 8 h post-administration, respectively, 55 mg/kg being the most effective dose. At this dose, a reduction in the plasmatic ACE activity in the SHR was found. However, Hpp11 did not relax the aortic ring preparations. Therefore, ACE inhibition could be the mechanism underlying Hpp11 antihypertensive effect. Remarkably, Hpp11 did not modify SBP in WKY rats, showing that the decreased SBP effect is specific to the hypertensive state.


Item Type:Article
Uncontrolled Keywords:hypertension; protein hydrolysate; angiotensin-converting enzyme; ACE-inhibitory activity; endothelial dysfunction; bioactive peptides
Subjects:Medical sciences > Medicine > Pharmacology
ID Code:65901
Deposited On:02 Jun 2021 14:48
Last Modified:02 Jun 2021 14:57

Origin of downloads

Repository Staff Only: item control page